Prostate tumor eccentricity predicts Gleason score better than prostate tumor volume

被引:5
|
作者
Mayer, Rulon [1 ,2 ]
Simone, Charles B., II [3 ]
Turkbey, Baris [4 ]
Choyke, Peter [4 ]
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Oncoscore, 10702 Keswick St, Garrett Pk, MD 20896 USA
[3] New York Proton Ctr, New York, NY USA
[4] NIH, Bldg 10, Bethesda, MD 20892 USA
关键词
Tumor morphology; prostate cancer (PCa); multi-parametric MRI; Gleason score; histology of wholemount prostatectomy; SEMINAL-VESICLE INVASION; RADICAL PROSTATECTOMY; CANCER VOLUME; ADENOCARCINOMA; MRI; BIOPSY; ALGORITHMS; SYSTEM;
D O I
10.21037/qims-21-466
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Prostate tumor volume predicts biochemical recurrence, metastases, and tumor proliferation. A recent study showed that prostate tumor eccentricity (elongation or roundness) correlated with Gleason score. No studies examined the relationship among the prostate tumor's shape, volume, and potential aggressiveness. Methods: Of the 26 patients that were analyzed, 18 had volumes >1 cc for the histology-based study, and 25 took up contrast material for the MRI portion of this study. This retrospective study quantitatively compared tumor eccentricity and volume measurements from pathology assessment sectioned wholemount prostates and multi-parametric MRI to Gleason scores. Multi-parametric MRI (T1, T2, diffusion, dynamic contrast enhanced images) were resized, translated, and stitched to form spatially registered multi-parametric cubes. Multi-parametric signatures that characterize prostate tumors were inserted into a target detection algorithm (Adaptive Cosine Estimator, ACE). Various detection thresholds were applied to discriminate tumor from normal tissue. Pixel-based blobbing, and labeling were applied to digitized pathology slides and threshold ACE images. Tumor volumes were measured by counting voxels within the blob. Eccentricity calculation used moments of inertia from the blobs. Results: From wholemount prostatectomy slides, fitting two sets of independent variables, prostate tumor eccentricity (largest blob eccentricity, weighted eccentricity, filtered weighted eccentricity) and tumor volume (largest blob volume, average blob volume, filtered average blob volume) to Gleason score in a multivariate analysis, yields correlation coefficient R=0.798 to 0.879 with P<0.01. The eccentricity t-statistic exceeded the volume t-statistic. Fitting histology-based total prostate tumor volume against Gleason score yields R=0.498, P=0.0098. From multi-parametric MRI, the correlation coefficient R between the Gleason score and the largest blob eccentricity for varying thresholds (0.30 to 0.55) ranged from R=-0.51 to -0.672 (P-values <0.01). For varying thresholds (0.60 to 0.80) for MRI detection, the R between the largest blob volume eccentricity against the Gleason score ranged from R=0.46 to 0.50 (P-values <0.03). Combining tumor eccentricity and tumor volume in multivariate analysis failed to increase Gleason score prediction. Conclusions: Prostate tumor eccentricity, determined by histology or MRI, more accurately predicted Gleason score than prostate tumor volume. Combining tumor eccentricity with volume from histology based analysis enhanced Gleason score prediction, unlike MRI.
引用
收藏
页码:1096 / 1108
页数:13
相关论文
共 50 条
  • [41] Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
    Vojtech Novak
    Stepan Vesely
    Hana Luksanová
    Richard Prusa
    Otakar Capoun
    Vojtech Fiala
    Olga Dolejsová
    Hana Sedlacková
    Radek Kucera
    Jiri Stejskal
    Miroslav Zalesky
    Marko Babjuk
    BMC Urology, 20
  • [42] Prognostic Value of Tumor Volume in Prostate Cancer
    Hilliges, C.
    Wiklund, F.
    Wiklund, P.
    Egevad, L.
    MODERN PATHOLOGY, 2012, 25 : 213A - 213A
  • [43] Prostate Cancer Tumor Volume and Genomic Risk
    Ramaswamy, Ashwin
    Proudfoot, James A.
    Ross, Ashley E.
    Davicioni, Elai
    Schaeffer, Edward M.
    Hu, Jim C.
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 48 : 90 - 97
  • [44] Prognostic Value of Tumor Volume in Prostate Cancer
    Hilliges, C.
    Wiklund, F.
    Wiklund, P.
    Egevad, L.
    LABORATORY INVESTIGATION, 2012, 92 : 213A - 213A
  • [45] Predictive preoperatory variables of the prostate tumor volume
    Loghin, Andrada
    Preda, O.
    Bacarea, V.
    Moldovan, C.
    Porav-Hodade, D.
    Dema, Alis
    Berger, Nicole
    Borda, Angela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 : 363 - 368
  • [46] A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy
    Green, GA
    Hanlon, AL
    Al-Saleem, T
    Hanks, GE
    CANCER, 1998, 83 (05) : 971 - 976
  • [47] Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer
    Novak, Vojtech
    Vesely, Stepan
    Luksanova, Hana
    Prusa, Richard
    Capoun, Otakar
    Fiala, Vojtech
    Dolejsova, Olga
    Sedlackova, Hana
    Kucera, Radek
    Stejskal, Jiri
    Zalesky, Miroslav
    Babjuk, Marko
    BMC UROLOGY, 2020, 20 (01)
  • [48] Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage
    Dassesse, Thibaut
    de Leval, Xavier
    de Leval, Laurence
    Pirotte, Bernard
    Castronovo, Vincent
    Waltregny, David
    EUROPEAN UROLOGY, 2006, 50 (05) : 1021 - 1031
  • [49] Association of polygenic risk score and prostate tumor biomarkers with lethal prostate cancer
    Wang, Anqi
    Plym, Anna
    Stopsack, Konrad H.
    Mucci, Lorelei A.
    Penney, Kathryn L.
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Correlation of tumor gene expression profile and gleason score (GS) in patients (pts) with metastatic prostate cancer.
    Sayegh, Nicolas
    Tripathi, Nishita
    Chigarira, Beverly
    Jo, Yeonjung
    Thomas, Vinay Mathew
    Nussenzveig, Roberto
    Sahu, Kamal Kant Kant
    Li, Haoran
    Gebrael, Georges
    Tandar, Clara
    Goel, Divyam
    Rathi, Nityam
    Maughan, Benjamin L.
    Swami, Umang
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41